Valeo’s net sales reached €5,046 million in first half 2005, an increase of 4.8% year on year.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
After adjusting for exchange rates (+0.6%) and changes in the reporting entity (+5.4% reflecting the acquisitions of the engine electronics division of Johnson Controls and the balance of the shareholding in Zexel Valeo Climate Control), sales were down 1.2% in line with the automobile production in Valeo’s key markets.
The gross margin for the half year fell by 2.7% to €825 million, representing 16.3% of sales as compared to €848 million and 17.6% of sales for the first half 2004. The group estimates that the increase in raw material prices reduced the gross margin was 1.5 points before corrective actions.
Operating income was €153 million or 3.0% of total operating revenues compared to €222 million and 4.6% of total operating revenues. The operating income includes a charge of €48 million under “other income/expense” as compared to a €25 million in 2004.
Income before tax for the period was €106 million as compared with €187 million in 2004. It includes a cost of financial debt of €24 million, an increase of €7 million compared to the first half 2004 as a result in particular of the acquisitions completed during the period.
The tax charge was €35 million as compared to €1 million in the first half 2004. The first half 2004 tax charge included a rebate of €83 million corresponding to the outstanding balance for the tax paid in 2001 on the gain from the sale of the Group’s 50% shareholding in LuK.
Net income was €73 million for the period compared to €183 million for the first half 2004. The comparison between the two years was impacted by the tax rebate of €83 million in 2004.
For the second half of the year, the group foresees a drop of between 1% and 2% in light vehicle production in Europe and a slight increase in North America boosted by the growth of the transplants. Valeo intends to continue to increase its market share and benefit from growth opportunities following its recent acquisitions.
